In another study, Kanda et al. found that higher GLP-1R expression in human endometrial cancer cell lines treated with liraglutide, a GLP-1 agonist, was significantly correlated with better progression-free survival (Kanda, 2018). This evidence concerns the gene GLP1R and endometrial cancer.